APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Japanese Encephalitis Virus Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Japanese Encephalitis Virus Vaccine Industry Growth and Trends Forecast to 2032

Report ID 174005170122 December 202594 pages

Choose your research edition.

Industry ResearchJapanese Encephalitis Virus Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Japanese Encephalitis Virus Vaccine Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Japanese Encephalitis Virus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Japanese Encephalitis Virus Vaccine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Japanese Encephalitis Virus Vaccine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Japanese Encephalitis Virus Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Japanese Encephalitis Virus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Japanese Encephalitis Virus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Japanese Encephalitis Virus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Japanese Encephalitis Virus Vaccine include Chengdu Institute, Liaoning Dacheng, Wuhan Institute, Valneva Austria GmbH and Research Foundation for Microbial Diseases of Osaka University, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Japanese Encephalitis Virus Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Japanese Encephalitis Virus Vaccine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Japanese Encephalitis Virus Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Japanese Encephalitis Virus Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Japanese Encephalitis Virus Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Japanese Encephalitis Virus Vaccine Market by Company

Chengdu Institute

Liaoning Dacheng

Wuhan Institute

Valneva Austria GmbH

Research Foundation for Microbial Diseases of Osaka University

Japanese Encephalitis Virus Vaccine Segment by Type

Inactivated Vaccine

Live Attenuated Vaccine

Japanese Encephalitis Virus Vaccine Segment by Application

Public

Private

Japanese Encephalitis Virus Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Japanese Encephalitis Virus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Japanese Encephalitis Virus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Japanese Encephalitis Virus Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Japanese Encephalitis Virus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Japanese Encephalitis Virus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Inactivated Vaccine Table 2. Major Company of Live Attenuated Vaccine Table 3. Global Japanese Encephalitis Virus Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Japanese Encephalitis Virus Vaccine Sales by Type (2021-2026) & (k units) Table 5. Global Japanese Encephalitis Virus Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Japanese Encephalitis Virus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Japanese Encephalitis Virus Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Japanese Encephalitis Virus Vaccine Price by Type (2021-2026) & (US$/unit) Table 9. Global Japanese Encephalitis Virus Vaccine Sales by Type (2027-2032) & (k units) Table 10. Global Japanese Encephalitis Virus Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Japanese Encephalitis Virus Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Japanese Encephalitis Virus Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Japanese Encephalitis Virus Vaccine Price by Type (2027-2032) & (US$/unit) Table 14. North America Japanese Encephalitis Virus Vaccine Sales by Type (2021-2026) & (k units) Table 15. North America Japanese Encephalitis Virus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Japanese Encephalitis Virus Vaccine Sales by Type (2021-2026) & (k units) Table 17. Europe Japanese Encephalitis Virus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Japanese Encephalitis Virus Vaccine Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Japanese Encephalitis Virus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Japanese Encephalitis Virus Vaccine Sales by Type (2021-2026) & (k units) Table 21. Latin America Japanese Encephalitis Virus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Japanese Encephalitis Virus Vaccine Industry Trends Table 25. Japanese Encephalitis Virus Vaccine Industry Drivers Table 26. Japanese Encephalitis Virus Vaccine Industry Opportunities and Challenges Table 27. Japanese Encephalitis Virus Vaccine Industry Restraints Table 28. Global Japanese Encephalitis Virus Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Japanese Encephalitis Virus Vaccine Sales by Company (2021-2026) & (k units) Table 31. Global Japanese Encephalitis Virus Vaccine Sales Share by Company (2021-2026) Table 32. Global Japanese Encephalitis Virus Vaccine Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Japanese Encephalitis Virus Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Japanese Encephalitis Virus Vaccine Major Company Production Sites and Headquarters Table 35. Global Japanese Encephalitis Virus Vaccine Company, Product Type & Application Table 36. Global Japanese Encephalitis Virus Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Japanese Encephalitis Virus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Japanese Encephalitis Virus Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Japanese Encephalitis Virus Vaccine Sales by Region (2021-2026) & (k units) Table 41. Global Japanese Encephalitis Virus Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Japanese Encephalitis Virus Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Japanese Encephalitis Virus Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Japanese Encephalitis Virus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Japanese Encephalitis Virus Vaccine Sales by Region (2027-2032) & (k units) Table 46. Global Japanese Encephalitis Virus Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Japanese Encephalitis Virus Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Japanese Encephalitis Virus Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Japanese Encephalitis Virus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Japanese Encephalitis Virus Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Japanese Encephalitis Virus Vaccine Sales by Application (2021-2026) & (k units) Table 52. Global Japanese Encephalitis Virus Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Japanese Encephalitis Virus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Japanese Encephalitis Virus Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Japanese Encephalitis Virus Vaccine Price by Application (2021-2026) & (US$/unit) Table 56. Global Japanese Encephalitis Virus Vaccine Sales by Application (2027-2032) & (k units) Table 57. Global Japanese Encephalitis Virus Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Japanese Encephalitis Virus Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Japanese Encephalitis Virus Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Japanese Encephalitis Virus Vaccine Price by Application (2027-2032) & (US$/unit) Table 61. North America Japanese Encephalitis Virus Vaccine Sales by Application (2021-2026) & (k units) Table 62. North America Japanese Encephalitis Virus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Japanese Encephalitis Virus Vaccine Sales by Application (2021-2026) & (k units) Table 64. Europe Japanese Encephalitis Virus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Japanese Encephalitis Virus Vaccine Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Japanese Encephalitis Virus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Japanese Encephalitis Virus Vaccine Sales by Application (2021-2026) & (k units) Table 68. Latin America Japanese Encephalitis Virus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Chengdu Institute Company Information Table 72. Chengdu Institute Business Overview Table 73. Chengdu Institute Japanese Encephalitis Virus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Chengdu Institute Japanese Encephalitis Virus Vaccine Product Portfolio Table 75. Chengdu Institute Recent Development Table 76. Liaoning Dacheng Company Information Table 77. Liaoning Dacheng Business Overview Table 78. Liaoning Dacheng Japanese Encephalitis Virus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Liaoning Dacheng Japanese Encephalitis Virus Vaccine Product Portfolio Table 80. Liaoning Dacheng Recent Development Table 81. Wuhan Institute Company Information Table 82. Wuhan Institute Business Overview Table 83. Wuhan Institute Japanese Encephalitis Virus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Wuhan Institute Japanese Encephalitis Virus Vaccine Product Portfolio Table 85. Wuhan Institute Recent Development Table 86. Valneva Austria GmbH Company Information Table 87. Valneva Austria GmbH Business Overview Table 88. Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Product Portfolio Table 90. Valneva Austria GmbH Recent Development Table 91. Research Foundation for Microbial Diseases of Osaka University Company Information Table 92. Research Foundation for Microbial Diseases of Osaka University Business Overview Table 93. Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Product Portfolio Table 95. Research Foundation for Microbial Diseases of Osaka University Recent Development Table 96. North America Japanese Encephalitis Virus Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 97. North America Japanese Encephalitis Virus Vaccine Sales by Country (2021-2026) & (k units) Table 98. North America Japanese Encephalitis Virus Vaccine Sales Market Share by Country (2021-2026) Table 99. North America Japanese Encephalitis Virus Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 100. North America Japanese Encephalitis Virus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 101. North America Japanese Encephalitis Virus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Japanese Encephalitis Virus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Japanese Encephalitis Virus Vaccine Market Share by Country (2021-2026) Table 104. North America Japanese Encephalitis Virus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Japanese Encephalitis Virus Vaccine Market Share Forecast by Country (2027-2032) Table 106. Europe Japanese Encephalitis Virus Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. Europe Japanese Encephalitis Virus Vaccine Sales by Country (2021-2026) & (k units) Table 108. Europe Japanese Encephalitis Virus Vaccine Sales Market Share by Country (2021-2026) Table 109. Europe Japanese Encephalitis Virus Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 110. Europe Japanese Encephalitis Virus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Japanese Encephalitis Virus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Japanese Encephalitis Virus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Japanese Encephalitis Virus Vaccine Market Share by Country (2021-2026) Table 114. Europe Japanese Encephalitis Virus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Japanese Encephalitis Virus Vaccine Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Japanese Encephalitis Virus Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Japanese Encephalitis Virus Vaccine Sales by Country (2021-2026) & (k units) Table 118. Asia-Pacific Japanese Encephalitis Virus Vaccine Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Japanese Encephalitis Virus Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 120. Asia-Pacific Japanese Encephalitis Virus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Japanese Encephalitis Virus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Japanese Encephalitis Virus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Japanese Encephalitis Virus Vaccine Market Share by Country (2021-2026) Table 124. Asia-Pacific Japanese Encephalitis Virus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Japanese Encephalitis Virus Vaccine Market Share Forecast by Country (2027-2032) Table 126. Latin America Japanese Encephalitis Virus Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Latin America Japanese Encephalitis Virus Vaccine Sales by Country (2021-2026) & (k units) Table 128. Latin America Japanese Encephalitis Virus Vaccine Sales Market Share by Country (2021-2026) Table 129. Latin America Japanese Encephalitis Virus Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 130. Latin America Japanese Encephalitis Virus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Japanese Encephalitis Virus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Japanese Encephalitis Virus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Japanese Encephalitis Virus Vaccine Market Share by Country (2021-2026) Table 134. Latin America Japanese Encephalitis Virus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Japanese Encephalitis Virus Vaccine Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Japanese Encephalitis Virus Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Country (2021-2026) & (k units) Table 138. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 140. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Japanese Encephalitis Virus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Japanese Encephalitis Virus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Japanese Encephalitis Virus Vaccine Market Share by Country (2021-2026) Table 144. Middle East and Africa Japanese Encephalitis Virus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Japanese Encephalitis Virus Vaccine Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Japanese Encephalitis Virus Vaccine Distributors List Table 149. Japanese Encephalitis Virus Vaccine Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Japanese Encephalitis Virus Vaccine Image Figure 2. Global Japanese Encephalitis Virus Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Japanese Encephalitis Virus Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Japanese Encephalitis Virus Vaccine Sales (2021-2032) & (k units) Figure 5. Inactivated Vaccine Image Figure 6. Global Inactivated Vaccine Sales YoY Growth (2021-2032) & (k units) Figure 7. Live Attenuated Vaccine Image Figure 8. Global Live Attenuated Vaccine Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Japanese Encephalitis Virus Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Japanese Encephalitis Virus Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Japanese Encephalitis Virus Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Japanese Encephalitis Virus Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Japanese Encephalitis Virus Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Japanese Encephalitis Virus Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Japanese Encephalitis Virus Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Japanese Encephalitis Virus Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Japanese Encephalitis Virus Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Japanese Encephalitis Virus Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Japanese Encephalitis Virus Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Public Image Figure 24. Global Public Sales YoY Growth (2021-2032) & (k units) Figure 25. Private Image Figure 26. Global Private Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Japanese Encephalitis Virus Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Japanese Encephalitis Virus Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Japanese Encephalitis Virus Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Japanese Encephalitis Virus Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Japanese Encephalitis Virus Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Japanese Encephalitis Virus Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Japanese Encephalitis Virus Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Japanese Encephalitis Virus Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Japanese Encephalitis Virus Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Japanese Encephalitis Virus Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Japanese Encephalitis Virus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Japanese Encephalitis Virus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Japanese Encephalitis Virus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Japanese Encephalitis Virus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Japanese Encephalitis Virus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Japanese Encephalitis Virus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Japanese Encephalitis Virus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Japanese Encephalitis Virus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Japanese Encephalitis Virus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Japanese Encephalitis Virus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Japanese Encephalitis Virus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Japanese Encephalitis Virus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Japanese Encephalitis Virus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Japanese Encephalitis Virus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Japanese Encephalitis Virus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Japanese Encephalitis Virus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Japanese Encephalitis Virus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Japanese Encephalitis Virus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Japanese Encephalitis Virus Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Japanese Encephalitis Virus Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated Vaccine
  • Live Attenuated Vaccine
Applications
  • Public
  • Private
Companies covered
  • Chengdu Institute
  • Liaoning Dacheng
  • Wuhan Institute
  • Valneva Austria GmbH
  • Research Foundation for Microbial Diseases of Osaka University

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Japanese Encephalitis Virus Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Japanese Encephalitis Virus Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Japanese Encephalitis Virus Vaccine Market by Type
  6. 1.3.1 Inactivated Vaccine
  7. 1.3.2 Live Attenuated Vaccine
  8. 1.4 Global Japanese Encephalitis Virus Vaccine Market Size by Type
  9. 1.4.1 Global Japanese Encephalitis Virus Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Japanese Encephalitis Virus Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Japanese Encephalitis Virus Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Japanese Encephalitis Virus Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Japanese Encephalitis Virus Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Japanese Encephalitis Virus Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Japanese Encephalitis Virus Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Japanese Encephalitis Virus Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Japanese Encephalitis Virus Vaccine Industry Trends
  2. 2.2 Japanese Encephalitis Virus Vaccine Industry Drivers
  3. 2.3 Japanese Encephalitis Virus Vaccine Industry Opportunities and Challenges
  4. 2.4 Japanese Encephalitis Virus Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Japanese Encephalitis Virus Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Japanese Encephalitis Virus Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Japanese Encephalitis Virus Vaccine Price (2021-2026)
  4. 3.4 Global Japanese Encephalitis Virus Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Japanese Encephalitis Virus Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Japanese Encephalitis Virus Vaccine Company, Product Type & Application
  7. 3.7 Global Japanese Encephalitis Virus Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Japanese Encephalitis Virus Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Japanese Encephalitis Virus Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Japanese Encephalitis Virus Vaccine Tier 1, Tier 2, and Tier 3
4 Japanese Encephalitis Virus Vaccine Regional Status and Outlook
  1. 4.1 Global Japanese Encephalitis Virus Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Japanese Encephalitis Virus Vaccine Historic Market Size by Region
  3. 4.2.1 Global Japanese Encephalitis Virus Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Japanese Encephalitis Virus Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Japanese Encephalitis Virus Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Japanese Encephalitis Virus Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Japanese Encephalitis Virus Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Japanese Encephalitis Virus Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Japanese Encephalitis Virus Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Japanese Encephalitis Virus Vaccine by Application
  1. 5.1 Japanese Encephalitis Virus Vaccine Market by Application
  2. 5.1.1 Public
  3. 5.1.2 Private
  4. 5.2 Global Japanese Encephalitis Virus Vaccine Market Size by Application
  5. 5.2.1 Global Japanese Encephalitis Virus Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Japanese Encephalitis Virus Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Japanese Encephalitis Virus Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Japanese Encephalitis Virus Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Japanese Encephalitis Virus Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Japanese Encephalitis Virus Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Japanese Encephalitis Virus Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Japanese Encephalitis Virus Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chengdu Institute
  2. 6.1.1 Chengdu Institute Company Information
  3. 6.1.2 Chengdu Institute Business Overview
  4. 6.1.3 Chengdu Institute Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chengdu Institute Japanese Encephalitis Virus Vaccine Product Portfolio
  6. 6.1.5 Chengdu Institute Recent Developments
  7. 6.2 Liaoning Dacheng
  8. 6.2.1 Liaoning Dacheng Company Information
  9. 6.2.2 Liaoning Dacheng Business Overview
  10. 6.2.3 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Product Portfolio
  12. 6.2.5 Liaoning Dacheng Recent Developments
  13. 6.3 Wuhan Institute
  14. 6.3.1 Wuhan Institute Company Information
  15. 6.3.2 Wuhan Institute Business Overview
  16. 6.3.3 Wuhan Institute Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Wuhan Institute Japanese Encephalitis Virus Vaccine Product Portfolio
  18. 6.3.5 Wuhan Institute Recent Developments
  19. 6.4 Valneva Austria GmbH
  20. 6.4.1 Valneva Austria GmbH Company Information
  21. 6.4.2 Valneva Austria GmbH Business Overview
  22. 6.4.3 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Product Portfolio
  24. 6.4.5 Valneva Austria GmbH Recent Developments
  25. 6.5 Research Foundation for Microbial Diseases of Osaka University
  26. 6.5.1 Research Foundation for Microbial Diseases of Osaka University Company Information
  27. 6.5.2 Research Foundation for Microbial Diseases of Osaka University Business Overview
  28. 6.5.3 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Product Portfolio
  30. 6.5.5 Research Foundation for Microbial Diseases of Osaka University Recent Developments
7 North America by Country
  1. 7.1 North America Japanese Encephalitis Virus Vaccine Sales by Country
  2. 7.1.1 North America Japanese Encephalitis Virus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Japanese Encephalitis Virus Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Japanese Encephalitis Virus Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Japanese Encephalitis Virus Vaccine Market Size by Country
  6. 7.2.1 North America Japanese Encephalitis Virus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Japanese Encephalitis Virus Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Japanese Encephalitis Virus Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Japanese Encephalitis Virus Vaccine Sales by Country
  2. 8.1.1 Europe Japanese Encephalitis Virus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Japanese Encephalitis Virus Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Japanese Encephalitis Virus Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Japanese Encephalitis Virus Vaccine Market Size by Country
  6. 8.2.1 Europe Japanese Encephalitis Virus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Japanese Encephalitis Virus Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Japanese Encephalitis Virus Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Japanese Encephalitis Virus Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Japanese Encephalitis Virus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Japanese Encephalitis Virus Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Japanese Encephalitis Virus Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Japanese Encephalitis Virus Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Japanese Encephalitis Virus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Japanese Encephalitis Virus Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Japanese Encephalitis Virus Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Japanese Encephalitis Virus Vaccine Sales by Country
  2. 10.1.1 South America Japanese Encephalitis Virus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Japanese Encephalitis Virus Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Japanese Encephalitis Virus Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Japanese Encephalitis Virus Vaccine Market Size by Country
  6. 10.2.1 South America Japanese Encephalitis Virus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Japanese Encephalitis Virus Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Japanese Encephalitis Virus Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Japanese Encephalitis Virus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Japanese Encephalitis Virus Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Japanese Encephalitis Virus Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Japanese Encephalitis Virus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Japanese Encephalitis Virus Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Japanese Encephalitis Virus Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Japanese Encephalitis Virus Vaccine Value Chain Analysis
  2. 12.1.1 Japanese Encephalitis Virus Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Japanese Encephalitis Virus Vaccine Production Mode & Process
  7. 12.2 Japanese Encephalitis Virus Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Japanese Encephalitis Virus Vaccine Distributors
  10. 12.2.3 Japanese Encephalitis Virus Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst